Deficient rains can be a bane for agri- and rural-centric companies, while a boon for sectors that offer respite from scorching heat
Freight traffic growth slowed to 3.5 percent in the second half of FY23 from 10.1 percent in H1 FY23
Business fundamentals look solid and the growth potential is very promising
After FMC Corp, Bayer has projected slower growth in calendar year 2023
The company has won majority of the projects awarded through tariff based competitive bidding (TBCB) in FY23
The fall in raw material prices accelerated since the Union Budget on February 1
Accenture is more diversified than India listed IT firms
A stock well positioned to benefit from the growth potential in agrochemical/industrial chemical space
The month of March could show sharp business growth for life insurers as Indians make their final dash to secure tax-free insurance policies before new rules kick in
If the banking turmoil adds to consumers’ anxiety about future incomes, it could trigger a deeper economic slowdown
Aggressive long-term expansion plans are in place with brownfield projects to be margin accretive for Max Healthcare in the near term
With the economy gaining momentum and supply challenges abating, Control Print is poised for strong growth
Electricity usage projected to scale new highs in April 2023
Pharma companies are likely to experience a recovery in margins, thanks to the easing of raw material costs and a reduction in price erosion in the US market.
The markets are pricing in a 100 basis point cut in the Fed Funds rate in one year
If he retired from TCS, Rajesh Gopinathan's tenure would have lasted for 13 more years. The new CEO's tenure will be for 7-8 years before he reaches retirement age
As deal wins gain ground, the IT major from the Tata stable is well placed to gain from this ongoing trend
Established Indian banks are better placed to weather the current storm
Jefferies predicts a 'softer impact on banking in India' as foreign banks constitute only 6 percent of banking assets, of which Credit Suisse accounts for 1.5 percent
Launch of two high value products faces delays and its manufacturing plants are under regulatory scrutiny
An international report reveals that India was the largest arms importer between 2018 and 2022 despite its drive to achieve self-reliance in defence production
ICICI Securities has a "buy" rating on Gujarat Fluorochemicals, Archean Chemical, Tatva Chintan, EPL, Chemplast Sanmar, PCBL in the specialty chemicals basket, along with a "hold" call for industry leader SRF.
Hospitals have inelastic demand and pricing power. But hospitals are capital intensive businesses and expansion puts stress on financials
The US banking system is dealing with the fallout of what happens when the central bank creates a more than decade-long easy money bubble and then tries to prick it in a short time
Worries have focused on credit and liquidity risks rather than interest rates